Trade CLDI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Calidi Biotherapeutics, Inc. (CLDI) is trading at US$1.04, up 2.97% today as of Oct 8, 16:00 EDT. The company has a market capitalisation of US$3.46M. Over the past 52 weeks, CLDI has traded between US$0.99 and US$27.84. On Syfe you can trade CLDI with $0 commission and add it to your watchlist.
| Previous close | US$1.01 |
|---|---|
| Market cap | US$3.46M |
| 52-week range | US$0.99 – US$27.84 |
| Volume | 18.21K |
| Exchange | US |
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
Year: 2023
Calidi Biotherapeutics to Effect 1-for-16 Reverse Stock Split
Jul 20, 8:58 PM · MT Newswires
Calidi Biotherapeutics Receives Positive Feedback From FDA for CLD-401 Pre-IND Application
Jun 16, 12:52 PM · MT Newswires
Calidi Biotherapeutics, Inc. (CLDI) stock is trading at US$1.04, +2.97% from the previous close of US$1.01.
The market cap for Calidi Biotherapeutics, Inc. (CLDI) stock is approximately US$3.46M.
The 52-week high for Calidi Biotherapeutics, Inc. (CLDI) stock is US$27.84.
The 52-week low for Calidi Biotherapeutics, Inc. (CLDI) stock is US$0.99.
Calidi Biotherapeutics, Inc. (CLDI) does not currently pay a dividend.
Stay on top of CLDI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
